PTIE - Pain Therapeutics Inc (Healthcare: Biotechnology) Projected Earnings Date: 2019-08-12    (Delayed quote data   2025-05-01)
Last
 1.62		 Change
 ⇑ +0.06   (+3.85%)		 Volume
  725,640
Open
 1.58		 High
 1.63		 Low
 1.54
8EMA (Daily)
 1.57		 40EMA (Daily)
 1.90		 50EMA (Daily)
 2.21		 STO (Daily)
 73.700		 MACD Hist (Daily)
 0.131
8EMA (Weekly)
 1.829		 40EMA (Weekly)
 9.15		 50EMA (Weekly)
 10.88		 STO (Weekly)
 15.885		 MACD Hist (Weekly)
 0.973
Company Profile
Pain Therapeutics Inc is a biopharmaceutical company that develops novel drugs. The Company has four drug candidates in clinical programs, including Remoxy, Oxytrex, PTI-202 and a novel radio-labeled monoclonal antibody to treat metastatic melanoma.
optionchance optionchance
⇒ Home | Chart and Research | Education | About Us  

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.

Questions or Comments: support@optionchance.com
Copyright © 2025 OptionChance.com